AstraZeneca PLC Files 6-K on Voting Rights

Ticker: AZN · Form: 6-K · Filed: Apr 1, 2026 · CIK: 0000901832

Astrazeneca PLC 6-K Filing Summary
FieldDetail
CompanyAstrazeneca PLC (AZN)
Form Type6-K
Filed DateApr 1, 2026
Risk Levellow
Pages2
Reading Time3 min
Key Dollar Amounts$0.25
Sentimentneutral

Sentiment: neutral

Topics: disclosure, voting-rights, foreign-issuer

TL;DR

AZN filed a 6-K on voting rights. Standard disclosure.

AI Summary

On April 1, 2026, AstraZeneca PLC filed a Form 6-K with the SEC, reporting its total voting rights and the admission of shares. The filing provides details on the company's mailing and business addresses in Cambridge, United Kingdom, and includes contact information.

Why It Matters

This filing provides essential information regarding AstraZeneca's share structure and voting rights, which is crucial for investors to understand their stake and influence in the company.

Risk Assessment

Risk Level: low — This is a routine disclosure filing that does not contain new financial information or significant operational updates.

Key Players & Entities

  • ASTRAZENECA PLC (company) — Filer
  • 0000901832 (company) — CIK
  • 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE United Kingdom CB2 0AA (location) — Mailing and Business Address
  • 011 44 20 7304 5000 (phone) — Contact Number

FAQ

What is the purpose of a Form 6-K filing?

A Form 6-K is a report of foreign issuer required by the SEC, used to submit information that the company has made or is required to make public in its home country.

When was this specific Form 6-K filed and accepted by the SEC?

This Form 6-K was filed and accepted on April 1, 2026.

What is AstraZeneca PLC's CIK number?

AstraZeneca PLC's CIK number is 0000901832.

Where are AstraZeneca PLC's primary business and mailing addresses located?

AstraZeneca PLC's primary business and mailing addresses are located at 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA.

What is the SIC code for AstraZeneca PLC?

The SIC code for AstraZeneca PLC is 2834, which corresponds to Pharmaceutical Preparations.

Filing Stats: 744 words · 3 min read · ~2 pages · Grade level 13.9 · Accepted 2026-04-01 10:30:32

Key Financial Figures

  • $0.25 — s is 1,550,980,823 ordinary shares of US$0.25. No shares are held in Treasury. Theref

Filing Documents

SIGNATURES

SIGNATURES   Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.     AstraZeneca PLC     Date: 01 April 2026     By: /s/ Matthew Bowden   Name: Matthew Bowden   Title: Company Secretary

View Full Filing

View this 6-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.